Skip to Main Content
June 22, 2021
Clinical Outcomes
Coverage and Benefit Design
Article / Publication

Source: The Journal of the American Medical Association

Authors: Monica E. Peek, MD, MPH, MS; Celeste C. Thomas, MD, MS

“…the studies by Karter et al. and Martens et al. provide additional evidence that patients with type 2 diabetes benefit from the use of CGM in terms of improved HbA1c level, time spent in the target blood glucose range, and reduced hypoglycemic episodes…”

“…institutional changes that promote its use in primary care will go a long way to improving diabetes control and reducing complications, particularly among the populations most in need. The time has come to broaden access to CGM for patients with type 2 diabetes.”

Learn More